Profile	GDS4460 / 244697_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	34.3	51
GSM803589	patient 7, baseline	40.9	52
GSM803592	patient 8, baseline	25.5	42
GSM803595	patient 10, baseline	84.3	63
GSM803598	patient 11, baseline	2.9	12
GSM803601	patient 12, baseline	8.5	22
GSM803604	patient 13, baseline	38.4	53
GSM803607	patient 14, baseline	74.6	63
GSM803610	patient 15, baseline	44.9	55
GSM803613	patient 16, baseline	5	17
GSM803587	patient 6, arm treated with pimecrolimus	5.4	19
GSM803590	patient 7, arm treated with pimecrolimus	168.2	76
GSM803593	patient 8, arm treated with pimecrolimus	17.9	34
GSM803605	patient 13, arm treated with pimecrolimus	72.9	64
GSM803608	patient 14, arm treated with pimecrolimus	64.8	61
GSM803599	patient 11, arm treated with pimecrolimus	25	44
GSM803611	patient 15, arm treated with pimecrolimus	73.8	63
GSM803614	patient 16, arm treated with pimecrolimus	38.7	52
GSM803602	patient 12, arm treated with pimecrolimus	63.9	60
GSM803596	patient 10, arm treated with pimecrolimus	436.5	89
GSM803591	patient 8, arm treated with betamethasone	25	44
GSM803609	patient 15, arm treated with betamethasone	304.6	84
GSM803597	patient 11, arm treated with betamethasone	105.1	68
GSM803585	patient 6, arm treated with betamethasone	79.5	63
GSM803603	patient 13, arm treated with betamethasone	270.2	83
GSM803612	patient 16, arm treated with betamethasone	68.7	61
GSM803588	patient 7, arm treated with betamethasone	287.4	83
GSM803594	patient 10, arm treated with betamethasone	289.4	84
GSM803600	patient 12, arm treated with betamethasone	330.8	86
GSM803606	patient 14, arm treated with betamethasone	331.4	85